Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Single-Dose, Open-label, Sequential, Three-Period Crossover Study to Evaluate the Pharmacokinetics of WD-1603 Tablets in Healthy Subjects

NCT03761004 is registered in ClinicalTrials.gov with Hong Kong WD Pharmaceutical Co., Limited as lead sponsor.

NCT NCT03761004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03761004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Single-Dose, Open-label, Sequential, Three-Period Crossover Study to Evaluate the Pharmacokinetics of WD-1603 Tablets in Healthy Subjects
Lead sponsor
Hong Kong WD Pharmaceutical Co., Limited
Phase
Phase 1
Overall status
Completed
Start date
January 14, 2019
Completion date
September 5, 2019
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers